Health Care & Life Sciences » Biotechnology | Prostemics Co. Ltd.

Prostemics Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
-
-
8,517
4,313
3,158
Depreciation, Depletion & Amortization
-
-
554
957
1,384
Other Funds
-
-
14,831
98
471
Funds from Operations
-
-
6,868
5,172
2,245
Changes in Working Capital
-
-
718
692
1,082
Net Operating Cash Flow
-
-
6,150
5,863
3,327
Capital Expenditures
-
-
7,118
5,875
2,598
Sale of Fixed Assets & Businesses
-
-
13
1,060
5
Purchase/Sale of Investments
-
-
1,984
4,438
12,194
Net Investing Cash Flow
-
-
4,932
9,075
9,742
Issuance/Reduction of Debt, Net
-
-
200
-
-
Net Financing Cash Flow
-
-
254
-
3,307
Net Change in Cash
-
-
1,064
3,026
2,911
Free Cash Flow
-
-
409
494
5,501
Other Sources
-
-
189
297
142
Change in Capital Stock
-
-
54
-
3,307
Exchange Rate Effect
-
-
100
185
197
Other Uses
-
-
-
119
-

About Prostemics Co.

View Profile
Address
3-4/F, Kyungwon Building
Seoul SL 06061
Korea, Republic Of
Employees -
Website http://www.prostemics.co.kr
Updated 09/14/2018
PROSTEMICS Co., Ltd. engages in the provision of stem cell cosmetics and medicine. It operates through cosmetic and stem cell medicine business divisions. The cosmetic business division provides cosmetics which contain stem cell culture medium.